FundedIQ
Biotechnology

GenAssist: Funding, Investors & Team (Oct 2026)

GenAssist started selling biomimetic sponges for the treatment of muscle loss in humans after noticing significant improvements in muscle function following a specific traumatic event that caused muscle loss.

genassist.co LinkedIn St Louis, United States 1-10 employees
Alternative Medicine Biopharma Biotechnology Open Source
Total raised
$80k
Rounds
1
Latest
Undisclosed round
Oct 2025

GenAssist has raised $80k across 1 funding round on record, the most recent an undisclosed round of $80k announced in Oct 2025.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

GenAssist Company Profile and Key Stats

Total funding raised
$80k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$80k in Oct 2025
Employees
1-10
reported band
Headquarters
St Louis, United States

Latest funding round on record: Oct 2025.

GenAssist Funding Rounds

Date
Round
Amount
Undisclosed round
$80k

GenAssist Founders and Leadership Team

Name
Role
Contact
Gabriel Haas
Founder
—

No contact details are on record for this team yet.

GenAssist Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

GenAssist's latest round of $80k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like GenAssist in Biotechnology and St Louis

Companies Similar to GenAssist

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

GenAssist Funding FAQs

What does GenAssist do?

GenAssist started selling biomimetic sponges for the treatment of muscle loss in humans after noticing significant improvements in muscle function following a specific traumatic event that caused muscle loss.

How much funding has GenAssist raised?

GenAssist has raised $80k across 1 round on record. The most recent is an undisclosed round of $80k announced in Oct 2025.

When did GenAssist last raise funding?

GenAssist's most recent funding round on record is an undisclosed round of $80k, announced in Oct 2025.

Who founded GenAssist?

FundedIQ lists Gabriel Haas (Founder) at GenAssist.

Where is GenAssist headquartered?

GenAssist is based in St Louis, Missouri, United States.

How many employees does GenAssist have?

GenAssist is in the 1-10 employee band.

How does GenAssist's funding compare to other Biotechnology startups?

GenAssist's latest round of $80k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's GenAssist Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GenAssist is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.